RxDoctor Payments DataLook up a doctor →

Anjali Advani, MD

Hematology · Cleveland, OHNPI 1942262738

Payments from drug & device makers

$6,875,012in general payments, 2019–2025

Across 290 payments — averaging $23,707 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$5.4M
  • Pfizer$311K
  • Servier Bioinnovation$265K
  • AbbVie$264K
  • Amgen$254K
  • Seagen Inc.$175K
  • plus $176K from 10 others
$20,020in research payments, 2019–2025

Across 14 payments — averaging $1430.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$20K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,875,012 in reported general payments places this provider in the 90th percentile of 84 hematology providers in Ohio.

See all hematology providers in Ohio

Medicare billing

Part B allowed, 2024
$33,551
Medicare patients
92
Services billed
356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →